secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-05-19T12:37:24+00:00
Accession:  0001178913-26-002797
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward appoints Keith D. Rose as Chief Medical Officer effective May 1, 2026
------------------------------------------------------------------------------

- Keith D. Rose, M.D. appointed Chief Medical Officer effective May 1, 2026.
- Dr. Rose joined Lifeward in March 2023; most recently VP, Medical Affairs, Medical Director – Neurosciences.
- Prior experience includes Medical Director at Biocodex and Clinical Research Scientist at Novocure (NVCR).
- Holds M.D. from George Washington University; residency at Baylor College of Medicine.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326002797/0001178913-26-002797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326002797/zk2635366.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-002797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer